Ceres Ventures, Inc. (CEVE) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCeres Ventures, Inc. (CEVE) trades at $0.0001. Ceres Ventures, Inc. is a development stage company focused on clean technology solutions for water, soil, and air remediation. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for CEVE: CEVE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Ceres Ventures, Inc. (CEVE) Healthcare & Pipeline Overview
Ceres Ventures, Inc., a development stage company, focuses on developing and commercializing clean technologies for environmental remediation, particularly in water treatment. Their BluFlow technologies aim to remove contaminants and extract valuable elements, positioning them within the growing market for sustainable water solutions. The company operates in the healthcare sector.
What Is the Investment Thesis for CEVE?
Ceres Ventures, Inc. presents a high-risk, high-reward investment profile typical of development stage companies in the clean technology sector. The company's BluFlow technologies target a significant market opportunity in water remediation and resource extraction. However, the company's lack of revenue and reliance on future commercialization pose substantial risks. Key value drivers include successful deployment and adoption of BluFlow technologies, securing partnerships, and obtaining regulatory approvals. The negative beta of -101.80 suggests an inverse correlation with the market, which is unusual and may reflect the company's speculative nature and limited trading activity. Investors should carefully consider the risks associated with development stage companies and the uncertainties surrounding the commercial viability of Ceres Ventures, Inc.'s technologies.
Based on FMP financials and quantitative analysis
CEVE Key Highlights
Ceres Ventures, Inc. is a development stage company focused on clean technology solutions.
- The company's core technologies include BluFlow Nanoparticles and Advanced Ultrafiltration.
- Ceres Ventures, Inc. targets the water remediation and resource extraction market.
- The company has a negative P/E ratio of -0.02, indicating it is not currently profitable.
- The company's beta is -101.80, indicating an inverse correlation with the market.
Who Are CEVE's Competitors?
CEVE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | $1.32 | +3.94% | — | |
| CCM Concord Medical Services Holdings Limited | $3.17 | +7.82% | — | |
| PIII P3 Health Partners Inc. | $6.36 | +1.44% | $20.8M | — |
| DCGO DocGo Inc. | $0.37 | -6.27% | $36.5M | — |
| BTMD biote Corp. | $1.15 | -0.86% | $50.7M | 67 5-pillar |
| JYNT The Joint Corp. | $7.28 | -2.54% | $104M | 70 5-pillar |
| AIRS AirSculpt Technologies, Inc. | $1.77 | +4.12% | $125M | 32 5-pillar |
| AUNA Auna S.A. | $5.06 | +1.61% | $375M | 70 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CEVE's Key Strengths?
Proprietary BluFlow technology
- Customizable solutions for specific applications
- Potential for resource extraction from water
- Focus on a growing market for sustainable solutions
What Are CEVE's Weaknesses?
Development stage company with limited revenue
- Reliance on future commercialization
- Limited financial resources
- Unproven track record
What Are the Key Risks for CEVE?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Development stage company with limited revenue and unproven track record.
- Competition from established water treatment companies with greater resources.
- Technological advancements by competitors rendering BluFlow technologies obsolete.
- Regulatory changes impacting water treatment standards and requiring costly compliance measures.
- Economic downturn affecting investment in clean technology and delaying commercialization.
What Are CEVE's Competitive Advantages?
- Proprietary BluFlow Nanoparticle technology
- Customizable solutions for targeted contaminant removal
- Integrated treatment system combining nanoparticles and ultrafiltration
- Potential for intellectual property protection through patents
What Does CEVE Do?
Ceres Ventures, Inc., formerly known as PhytoMedical Technologies, Inc. until November 2011, is a development stage company dedicated to the research, development, and commercialization of clean technologies. Headquartered in New York City, the company focuses on remediating polluted water, soil, and air through innovative solutions. Their primary technologies revolve around the BluFlow system, encompassing BluFlow Nanoparticles, BluFlow Advanced Ultrafiltration Technology, and the BluFlow Treatment System. The BluFlow Nanoparticles are a proprietary system designed for formulating, producing, and deploying customizable absorbent nanoparticles. These nanoparticles are engineered for specific functionalities, enabling the removal of contaminants and chemicals, as well as the extraction of valuable elements and compounds from water-based solutions. The BluFlow Advanced Ultrafiltration Technology is an automated process aimed at recovering water from waste or impure streams, enhancing water reuse possibilities. The BluFlow Treatment System integrates both Nanoparticles and Ultrafiltration technologies to provide a comprehensive water and wastewater treatment solution, removing target elements, compounds, and pollutants to purify water for potential reuse. Ceres Ventures, Inc.'s technologies find application in various sectors, including water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and the extraction of valuable elements and compounds. As a development stage company, Ceres Ventures, Inc. is focused on further developing and commercializing its technologies to address the growing demand for sustainable environmental solutions.
What Products and Services Does CEVE Offer?
- Researches and develops clean technologies for environmental remediation.
- Focuses on water, soil, and air pollution solutions.
- Develops BluFlow Nanoparticles for contaminant removal and resource extraction.
- Offers BluFlow Advanced Ultrafiltration Technology for water recovery.
- Provides BluFlow Treatment System for water and wastewater purification.
- Targets applications in water treatment, groundwater treatment, and industrial wastewater treatment.
How Does CEVE Make Money?
- Develop and commercialize clean technology solutions.
- Generate revenue through the sale of BluFlow Nanoparticles, Ultrafiltration Technology, and Treatment Systems.
- Seek partnerships with municipalities and industrial clients.
- Potentially generate revenue through licensing agreements.
What Industry Does CEVE Operate In?
Ceres Ventures, Inc. operates within the environmental remediation and water treatment industry, a sector driven by increasing environmental regulations, growing water scarcity, and the need for sustainable resource management. Competitors include companies like ASFX, CBGI, HSMD, LOWLF, and MDIT, which offer various water treatment solutions. Ceres Ventures, Inc. aims to differentiate itself through its BluFlow technologies, offering customizable nanoparticle solutions for targeted contaminant removal and resource extraction.
Who Are CEVE's Key Customers?
- Municipal water treatment facilities
- Industrial companies generating wastewater
- Government agencies involved in environmental remediation
- Companies involved in resource extraction from water
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for Ceres Ventures, Inc. stands at 225.9%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.21 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Ceres Ventures, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in New York City, US. The company is led by CEO Frank J. Fabio. CEVE has traded publicly since 1995.
Financial Health
Ceres Ventures, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CEVE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
CEVE Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Oct 4, 2019
CEVE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CEVE.
Price Targets
Wall Street price target analysis for CEVE.
CEVE MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CEVE; grades run from A+ (80-100) to F (below 30).
Leadership: Frank J. Fabio
CEO
Frank J. Fabio serves as the CEO of Ceres Ventures, Inc. As CEO, he is responsible for leading the company's strategic direction, overseeing operations, and driving the commercialization of its BluFlow technologies. His leadership is crucial in navigating the challenges of a development stage company and securing partnerships for growth.
Track Record: Frank J. Fabio's track record at Ceres Ventures, Inc. is difficult to assess due to the company's development stage and lack of significant commercial activity. Key milestones under his leadership would include securing funding, advancing the development of BluFlow technologies, and establishing partnerships. Further information is needed to evaluate his performance and strategic decisions.
CEVE OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by speculative securities with limited or no financial disclosure. Companies in this tier may not meet minimum financial standards or reporting requirements, leading to increased risk for investors. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to stringent listing standards, resulting in less transparency and regulatory oversight. Investing in OTC Other stocks carries significant risks due to the lack of information and potential for fraud or manipulation.
- OTC Tier: OTC Other
- Limited or no financial disclosure
- Low liquidity and wide bid-ask spreads
- Potential for fraud or manipulation
- Lack of regulatory oversight
- Speculative nature of the securities
- Verify the company's registration and legal standing
- Obtain and review any available financial information
- Assess the company's business model and market opportunity
- Evaluate the management team and their experience
- Understand the risks associated with the company's industry
- Consult with a financial advisor
- Be prepared to lose your entire investment
- Company website and contact information
- Press releases and news coverage
- Any available financial reports or disclosures
- Information on management team and board members
- Independent verification of claims and technologies
What Investors Ask About Ceres Ventures, Inc. (CEVE) — Healthcare
What do analysts say about CEVE stock?
As of March 16, 2026, there is no available analyst coverage or consensus on Ceres Ventures, Inc. (CEVE) stock. This is likely due to the company's development stage, limited trading activity on the OTC market, and lack of financial disclosure.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on available sources and may be limited due to the company's development stage and OTC listing.
- Financial data may not be current or readily available.